Evogene beats by $0.03, misses on revenues

Evogene (EVGN): Q1 EPS of -$0.09 beats by $0.03.

Revenue of $3.85M (-16.4% Y/Y) misses by $1.09M.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs